Skip to main content

Diabetic Retinopathy Market Insights, Regional Outlook And Forecasts 2022: Credence Research

According to the latest report published by Credence Research, Inc. “Diabetic Retinopathy Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  global diabetic retinopathy market was valued at USD 7.9 Bn in 2015, and is expected to reach USD 12.6 Bn by 2022, expanding at a CAGR of 6.7% from 2016 to 2022.
Browse the full report Diabetic Retinopathy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/diabetic-retinopathy-market
Market Insights:
Perpetual growth in the prevalence of diabetes in middle- and low-income countries and further anticipation of future rise indicates the growth in prevalence of diabetic related complications, and hence diabetic retinopathy. Diabetic retinopathy is among the key causes of legal blindness in working adult population. With overall prevalence of around 34% in the total diabetes population, the burden in form of direct and indirect management cost of diabetic retinopathy is humongous. Treatment for diabetic retinopathy is determined upon the severity of condition, where non-proliferative diabetic retinopathy is excuses from treatment.
Along with high prevalence of diabetes and hence diabetic retinopathy, wide availability of treatment options also serve as key drivers of this market. At present, diabetic retinopathy is mostly treated with laser treatment and vitrectomy. As the prevalence of macular edema in diabetic retinopathy is on rise, it is anticipated that the demand for treatment drugs and injections will steadily grow. Rise in healthcare expenditure is another key contributor to the growth of diabetic retinopathy market. However, the market growth may be shunted due to shortage of skilled professional for treating diabetes and related complications. The key diabetic retinopathy treatment drugs studied in this report are Aflibercept (Eylea), Bevacizumab (Avastin), Fluocinolone acetonide (Iluvien), Ranibizumab (Lucentis) and Triamcinolone acetonide.
Geographically, this report studies the diabetic retinopathy for North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America markets. These regions are further split into key country-level markets that determine the overall trends in respective regional market. Among the considered geographies, North America and Europe together take over 50% of the global market share for diabetic retinopathy treatments. High awareness, early introduction of breakthrough treatment devices and drugs, extensive research initiatives being taking place in the U.S. and Western Europe and favorable reimbursements are the key factors that contribute to the dominance of these regions.
Phenomenal rise in prevalence of diabetes in India, China and other middle- and low-income countries of Asia-Pacific and Middle East and Africa make these regions the fastest growing geographical markets during the forecast period. Other drivers of diabetic retinopathy market in Asia-Pacific and Middle East and Africa markets are rapid development of healthcare infrastructure, growing focus of market players to develop their foothold in Asia and Middle East markets, and growing government and non-government initiatives for developing awareness about diabetes management in the general population.
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Diabetic Retinopathy Treatment Devices Market, by Type, 2015 (USD Mn)
2.2 Diabetic Retinopathy Treatment Drugs Market, by Type, 2015 (USD Mn)
2.3 Diabetic Retinopathy Market Share, by Geography, 2015 (Value %)
Chapter 3 Diabetic Retinopathy Market: Market Dynamics and Outlook
3.1 Introduction
3.2 Diabetic Retinopathy: Facts and Figures
3.3 Drivers
3.4 Challenges
3.5 Future Prospects
3.6 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Popular posts from this blog

Algae Products Market Key Growth Factors and Industry Analysis 2023: Credence Research

According to a new market report published by Credence Research “ Algae Products Market  - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023,” the algae products market is expected to reach US$ 44.7 Bn by 2023, expanding at a CAGR of more than 5.0% from 2016 to 2023. Browse the full report at  http://www.credenceresearch.com/report/algae-products-market Market Insights: Algae are a diverse group of photosynthetic organisms which are not closely related and hence are known to be polyphyletic. They are plats which range from microalgae to macro algae. Algae are grown using water resources such as sea and waste water which are not suitable for growing agricultural crops. Microalgae grow using sunlight i.e. photosynthesis, by converting sunlight, CO2 and nutrients such as phosphorus and nitrogen into biomass. This growth is also known as autotrophic growth. Some algae can grow in the dark using sugar starch or by combining both the growth modes. Based on applica

Base Oil Market Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 – 2023: Credence Research

Credence Research has recently issued a new market assessment report titled “Base Oil – Growth, Future Prospects and Competitive Analysis, 2016 – 2023”. The global Base Oil Market study provides a comprehensive view of the ongoing and future phases of the Base Oil industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/base-oil-market Based on geographic/regional distribution the global Base Oil Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Base Oil Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Ba

Articulated Arm Machine Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023

According to a new market report published by Credence Research, Inc., “ Articulated Arm Machine Market  (By End-use Application (Industrial Manufacturing, Automotive, Electronics and Electrical, Aerospace, Energy and Power, and Other End-use Applications), By Price (Low-end Articulated Arms, Mid-range Articulated Arms, and High-end Articulated Arms)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 - 2023”, the global articulated arm machine market is expected to witness steady growth in demand, expanding at a CAGR of 8.2% during the forecast period 2016 to 2023. Browse the full Articulated Arm Machine (By End-use Application (Industrial Manufacturing, Automotive, Electronics and Electrical, Aerospace, Energy and Power, and Other End-use Applications), By Price (Low-end Articulated Arms, Mid-range Articulated Arms, and High-end Articulated Arms)) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023 report at  http://www.crede